Member Info for researchit

I think we may as well forget all about the bid now. The company seems to be well and truly on its way to recovery now anyway, and with the newish CFO having been in place for a couple of months now there financial debacles of the passt 12 months or so should be sorted. I think shareholders should now be just paid out there overdue divi which has been held up by Avgol, and the company sholud be left alone to motor forward

what evidence do you have that news will come thick and fast , is this based on knowledge or guess work ? if based on knowledge , then what knowledge

I tend to agree with you , it always seems that the release of big information that we have grown to expect from QTI never quite materialises and your always left feeling somewhat underwhelmed when finally they do get around to giving out an rns. Does Tapia really have the necessary buisness acumen to go with his development talent, that's only something that Tapia himself can answer with big orders !

Anybody any ideas as to why the price dive in the past couple of hours, facts preferable to subjuncture. I can't find any news but these are getting well and truly stiffed. Have Avgol walked ??????

Sorry I got the info confused, but I concur that 100p if present trading is as is told, is closer to fair value

Not sure about lge late trade yesterday , but confidence doesn't seem to have broken yet. Pretty resilient recovery thus far......hopefully it will hold

Don't be so quick to put a hatchet in the back of Avgols bid for FWEB , in such rough seas as these at present it would be easy for Avgol to have jumped ship on this deal and sat back snuggly on its laurels in Israel. Avgol so I'm informed are quite a dynamic and progressive company who belive they need this deal to propel them forward to the big league and have shown some resilience to market uncertainties by sticking with this deal. That's why , so I'm told, the institutions are keeping a foot in on this one in the belief that it just could come off. However like you I belive that FWEB's troubles could be behind them now and they seem to have regained focus , so deal or no deal I'll be sticking with them as I see increasing demand for there products , with better margins ahead now that they have these recently announced deals in India and China

On the 22 Jan it was announced that FWEB were in t/o talks with Avgol . Pretty much 8 weeks later there has been no more info. Does anyone have any idea as to how much longer this could possibly go on for ???????

QTI announced back in September that they were sending Leakfrog out to there major customers and utilities on a 3 month trial and we were to expect results and follow up orders to have been announced by now, long before now, are we to take it that the trials were unsucessful and no new orders were forth coming or is it just another case of Tapia not keeping his investors informed . It really is about time that Tapia started to announce some big orders , pulled his finger out and really started to push on and realise the full potential of these products , otherwise the momentum that the company had towards the back end of last year will wain yet further and shareholders will lope off and take there funds elsewhere to companies that deem investor relations of greater importance.

I'd say buy. At the moment we're in a bit of a lull as we wait for news on order progress with the leakfrog , that's why it can't push on above 2.40, but I'm pretty confident that the orders will indeed come , and when they do the sp will rise quite nicely , although no predictions as it's just subjuncture in the present climate

the articles are both from back in mid January and the ft.com article referring to initial discussions and 75p rejected bid were quoted as coming from a source . Anything that comes from an un-named source is nothing more than speculation . I would suggest that the piece coming from the Herald is somewhat superceded by now as it is six weeks old and the deal would have collapsed by now if the money was not available.

when exactly did Avgol put in a bid of 75p for Fiberweb ? You say that Fiberweb have been in takeover talks for over a year now , so where's the rns ? The provisional bid was made long after the credit crunch so to reason that Avgol do not have the finance facility already in place is quite fancifull and not very informed. Discussion boards can be a great source of information as long as people stick to facts !!

There isn't actually a bid on the table . There is a theoretical bid on the table if after due dilligance they decide to progress with a full bid.

Bad results were always on the cards , that's why we had 3 profit warnings last year and the fall from 226. The directors were buying in droves at 52 mark around Oct last year which is kind of what signalled the bottom for me , since then weve had new CFO with history of successful t/o negotiations behind him

I couldn't quite understand the sp rise yesterday after results that on the surface were quite horrific but think if you look a bit deeper you can see that they decided to air all the garbage news in one go and inform everyone that they are now infact on a much firmer footing with extra capacity and new products that are going to increase turnover, The company cut its debt by 33.1 mln stg also last year in spite of there problems. Clearly Avgol have not yet been frightened off and if you add to this the good news yesterday of the tie ups in China and India which should bring extra revenue and savings then you can start to see a much rosier picture and understand why Tettamanti is adding stock, and why the likes of DuPont and others are rumoured to be circling.

Acambis PLC said the US Department of Defense (DoD) is transitioning to the company's ACAM2000 as its only smallpox vaccine. Dryvax, the vaccine in use since 2002, will continue to be used till Feb 29, after which ACAM2000 will be the sole vaccine. This is surely a significant piece of business for Acambis and should elevate it quickly to much higher levels previously experianced when it was the main smallpox vaccine provider a couple of years ago

Now that Acambis has teamed up with Sanofi-Aventis in the development of its WNV vaccine and with Crucell dropping their WNV from their trials this share now looks significantly underrated.

IDMoS had earlier said it expects its performance to fall significantly short of the market expectations, due to a lower-than-expected market take up of its products.

Qonnectis PLC said it has agreed to allot 25 mln shares to Security Change Ltd to pay back the principal amount of the loan stock

Not researcced these at all. o can anyone tell me , do they have anything other than this well ???